misonidazole has been researched along with Ovarian Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coombs, A; Hanson, J; Moore, JL | 1 |
Kleine, W; Ladner, HA; Nagy, D; Stange, S | 1 |
Collins, JM; Gianni, L; Greene, RF; Jenkins, JF; Lichter, AS; Myers, CE | 1 |
Ozols, RF; Poirier, MC; Reed, E; Tarone, R; Yuspa, SH | 1 |
Lichter, AS; Myers, CC; Ostechega, Y; Ozols, RF; Young, RC | 1 |
5 other study(ies) available for misonidazole and Ovarian Neoplasms
Article | Year |
---|---|
Drug testing using a soft agar stem cell assay on patient and xenograft tumor material.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colony-Forming Units Assay; Drug Synergism; Etoposide; Female; Granulosa Cell Tumor; Humans; Melphalan; Methotrexate; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms; Ovarian Neoplasms; Transplantation, Heterologous; Tumor Stem Cell Assay; Vinblastine | 1984 |
[Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
Topics: Animals; Cobalt Radioisotopes; Female; Genital Neoplasms, Female; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Ovarian Neoplasms; Radiotherapy, High-Energy; Uterine Cervical Neoplasms; Uterine Neoplasms | 1982 |
Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
Topics: Female; Humans; Injections, Intraperitoneal; Kinetics; Misonidazole; Nitroimidazoles; Ovarian Neoplasms; Radiation-Sensitizing Agents | 1983 |
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Drug Evaluation; Female; Humans; Middle Aged; Misonidazole; Organoplatinum Compounds; Ovarian Neoplasms | 1987 |
The treatment of advanced stage ovarian carcinoma with a combination of chemotherapy, radiotherapy, and radiosensitizer: report of a pilot study from the National Cancer Institute.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Middle Aged; Misonidazole; Ovarian Neoplasms; Pilot Projects; Prognosis; Radiation-Sensitizing Agents | 1987 |